Region:Asia
Author(s):Rebecca
Product Code:KRAB2129
Pages:94
Published On:January 2026

By Product Type:The product type segmentation includes various categories such as Veterinary Drugs, Vaccines, Medicated Feed Additives, Nutritional & Nutraceutical Products, Diagnostic & Supportive Therapeutics, and Others. Veterinary Drugs, particularly anti-infectives and anti-inflammatories, represent a major share of usage in livestock and companion animals due to the continued prevalence of infectious diseases and the need to manage productivity and welfare. Preventive healthcare through vaccines is increasingly emphasized in commercial farms as part of biosecurity strategies to control endemic and emerging animal diseases, while medicated feed additives and nutritional products are used to enhance growth performance, immunity, and feed efficiency.

By Route of Administration:The route of administration includes Oral, Parenteral (Injectable), Topical, and Others. The oral route is widely used in Vietnam’s livestock sector because it is suitable for mass treatment or prevention via feed and water, aligning with commercial poultry and swine production practices. Parenteral administration is essential for vaccines and high-value therapeutics that require precise dosing and rapid onset of action, particularly in companion animals and high-value breeding stock, while topical formulations are used for ectoparasite control and dermatological conditions in both farm and companion animals.

The Vietnam Veterinary Pharmaceuticals Market is characterized by a dynamic mix of regional and international players. Leading participants such as Zoetis, Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim, and Virbac contribute to innovation, geographic expansion, and service delivery in this space, often working through local subsidiaries and distribution partners to supply vaccines, anti-infectives, parasiticides, and specialty therapeutics.
The Vietnam veterinary pharmaceuticals market is poised for significant growth, driven by increasing pet ownership and rising livestock health awareness. The trend towards organic and natural veterinary products is expected to gain momentum, reflecting consumer preferences for sustainable options. Additionally, advancements in digital veterinary services, including telemedicine, will enhance access to care. As the government continues to support animal health initiatives, the market will likely see increased investment and innovation, positioning it for a dynamic future.
| Segment | Sub-Segments |
|---|---|
| By Product Type | Veterinary Drugs (Anti-infectives, Anti-inflammatories, Others) Vaccines Medicated Feed Additives Nutritional & Nutraceutical Products Diagnostic & Supportive Therapeutics Others |
| By Route of Administration | Oral Parenteral (Injectable) Topical Others |
| By Animal Type | Livestock (Cattle, Swine, Poultry, Others) Companion Animals Aquaculture Others |
| By Application | Disease Prevention (Prophylactic) Treatment & Control (Therapeutic) Productivity & Performance Enhancement Others |
| By Distribution Channel | Veterinary Hospitals Veterinary Clinics Pharmacies & Drug Stores Online Channels Distributors / Wholesalers Others |
| By Region | Northern Vietnam Central Vietnam Southern Vietnam |
| By Policy Support | Government Subsidies for Veterinary Products Tax Incentives for Manufacturers Research & Innovation Grants Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Veterinary Clinics | 90 | Veterinarians, Clinic Managers |
| Livestock Farmers | 120 | Farm Owners, Livestock Managers |
| Pharmaceutical Distributors | 70 | Sales Managers, Distribution Coordinators |
| Regulatory Bodies | 40 | Policy Makers, Regulatory Affairs Specialists |
| Research Institutions | 60 | Researchers, Veterinary Scientists |
The Vietnam Veterinary Pharmaceuticals Market is valued at approximately USD 1.1 billion, driven by a recovering livestock sector, increasing demand for animal protein, and rising investments in animal health.